Volver a Agenda
Session Chair(s)
Liz Wool, BSN
President
Wool Consulting Group Inc., United States
Learning Objective : Identify the foundational principles discussed in the Part 1 workshop to develop a study risk plan; Perform critical analysis of study risk plan.
Speaker(s)
Facilitator
Johann Proeve, PHD
Cyntegrity, Germany
Chief Scientific Officer
Facilitator
Kristin M. Neff, MS
InVivo Therapeutics, United States
Vice President, Clinical Operations and Project Management
Facilitator
Dale Usner, PHD
Statistics & Data Corporation (SDC), United States
CSO and Sr. VP, Strategic Scientific Consulting
¿Tiene una cuenta?